173 related articles for article (PubMed ID: 24141136)
21. [Chemical proteomics and discovery of drug targets].
Yang HQ; Li XJ
Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
[TBL] [Abstract][Full Text] [Related]
22. Use of high-throughput LC-MS/MS proteomics technologies in drug discovery.
Shen Z; Wang MW; Briggs SP
Drug Discov Today Technol; 2006; 3(3):301-6. PubMed ID: 24980532
[TBL] [Abstract][Full Text] [Related]
23. Analytical strategies in mass spectrometry-based phosphoproteomics.
Rosenqvist H; Ye J; Jensen ON
Methods Mol Biol; 2011; 753():183-213. PubMed ID: 21604124
[TBL] [Abstract][Full Text] [Related]
24. Chemical proteomics and its impact on the drug discovery process.
Miao Q; Zhang CC; Kast J
Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
[TBL] [Abstract][Full Text] [Related]
25. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways.
Kosako H; Nagano K
Expert Rev Proteomics; 2011 Feb; 8(1):81-94. PubMed ID: 21329429
[TBL] [Abstract][Full Text] [Related]
26. Quantitative phosphoproteomics--an emerging key technology in signal-transduction research.
Schreiber TB; Mäusbacher N; Breitkopf SB; Grundner-Culemann K; Daub H
Proteomics; 2008 Nov; 8(21):4416-32. PubMed ID: 18837465
[TBL] [Abstract][Full Text] [Related]
27. Antibody-based proteomics and biomarker research - current status and limitations.
Solier C; Langen H
Proteomics; 2014 Mar; 14(6):774-83. PubMed ID: 24520068
[TBL] [Abstract][Full Text] [Related]
28. [Advances in analysis techniques of phosphoproteome].
Yang J; Zou QM; Cai SX; Guo G; Zhu YH
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):244-8. PubMed ID: 15966331
[TBL] [Abstract][Full Text] [Related]
29. Protein arrays for biomarker discovery.
Reid JD; Parker CE; Borchers CH
Curr Opin Mol Ther; 2007 Jun; 9(3):216-21. PubMed ID: 17608019
[TBL] [Abstract][Full Text] [Related]
30. Phosphoproteomics: miles to go before it's routine.
Piggee C
Anal Chem; 2009 Apr; 81(7):2418-20. PubMed ID: 19275151
[TBL] [Abstract][Full Text] [Related]
31. Proteomic strategies to characterize signaling pathways.
Harsha HC; Pinto SM; Pandey A
Methods Mol Biol; 2013; 1007():359-77. PubMed ID: 23666735
[TBL] [Abstract][Full Text] [Related]
32. Phosphoproteomics in bacteria: towards a systemic understanding of bacterial phosphorylation networks.
Jers C; Soufi B; Grangeasse C; Deutscher J; Mijakovic I
Expert Rev Proteomics; 2008 Aug; 5(4):619-27. PubMed ID: 18761471
[TBL] [Abstract][Full Text] [Related]
33. Phosphoproteomics--finally fulfilling the promise?
Rogers LD; Foster LJ
Mol Biosyst; 2009 Oct; 5(10):1122-9. PubMed ID: 19756301
[TBL] [Abstract][Full Text] [Related]
34. Phosphoproteomic profiling of the myocyte.
Edwards AV; Cordwell SJ; White MY
Circ Cardiovasc Genet; 2011 Oct; 4(5):575. PubMed ID: 22010164
[TBL] [Abstract][Full Text] [Related]
35. Antibody-based technologies for target discovery.
Valle RP; Jendoubi M
Curr Opin Drug Discov Devel; 2003 Mar; 6(2):197-203. PubMed ID: 12669455
[TBL] [Abstract][Full Text] [Related]
36. Quantitative measurement of phosphopeptides and proteins via stable isotope labeling in Arabidopsis and functional phosphoproteomic strategies.
Li N
Methods Mol Biol; 2012; 876():17-32. PubMed ID: 22576083
[TBL] [Abstract][Full Text] [Related]
37. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
38. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples.
Narumi R; Murakami T; Kuga T; Adachi J; Shiromizu T; Muraoka S; Kume H; Kodera Y; Matsumoto M; Nakayama K; Miyamoto Y; Ishitobi M; Inaji H; Kato K; Tomonaga T
J Proteome Res; 2012 Nov; 11(11):5311-22. PubMed ID: 22985185
[TBL] [Abstract][Full Text] [Related]
39. Mass spectrometry-based proteomics in preclinical drug discovery.
Schirle M; Bantscheff M; Kuster B
Chem Biol; 2012 Jan; 19(1):72-84. PubMed ID: 22284356
[TBL] [Abstract][Full Text] [Related]
40. Tyrosine phosphoproteomics and identification of substrates of protein tyrosine phosphatase dPTP61F in Drosophila S2 cells by mass spectrometry-based substrate trapping strategy.
Chang YC; Lin SY; Liang SY; Pan KT; Chou CC; Chen CH; Liao CL; Khoo KH; Meng TC
J Proteome Res; 2008 Mar; 7(3):1055-66. PubMed ID: 18281928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
